University of Michigan Comprehensive Cancer Center SC-2 — Ann Arbor, Michigan

University of Michigan Comprehensive Cancer Center SC-2 is a clinical research site located in Ann Arbor, Michigan, United States 48109-0944.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Michigan Comprehensive Cancer Center SC-2 has participated in 2 clinical trials.

Therapeutic areas: Cushing's Disease, Acromegaly, Neuroendocrine Tumors.

Sponsors: Novartis Pharmaceuticals, RECORDATI GROUP.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Michigan Comprehensive Cancer Center SC-2?

University of Michigan Comprehensive Cancer Center SC-2 has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Michigan Comprehensive Cancer Center SC-2 conducted?

University of Michigan Comprehensive Cancer Center SC-2 has 2 clinical trials on record. Their work covers Cushing's Disease, Acromegaly, Neuroendocrine Tumors.

Is University of Michigan Comprehensive Cancer Center SC-2 accredited by Crixeo Health?

University of Michigan Comprehensive Cancer Center SC-2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Michigan Comprehensive Cancer Center SC-2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.